<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ORTX
Acquired by Kyowa Kirin
$
()


  • Orchard Therapeutics outlines U.S. launch plans for Lenmeldy

    3/20/2024 - 07:15am
  • Orchard Therapeutics announces FDA approval of Lenmeldy

    3/18/2024 - 15:43pm
  • Two new option listings and option delistings on February 26th

    2/26/2024 - 08:30am
  • Orchard Therapeutics announces first patient randomized in trial of OTL-203

    2/5/2024 - 07:13am
  • Orchard enters agreement with Beneluxa enabling reimbused access to Libmeldy

    1/25/2024 - 07:12am
  • Soleno Therapeutics announces appointments to its leadership team

    1/24/2024 - 08:07am
  • Orchard Therapeutics receives Swissmedic approval for Libmeldy

    12/11/2023 - 07:25am
  • Orchard Therapeutics receives U.S. fast track designation for OTL-203

    11/30/2023 - 07:03am
  • Orchard Therapeutics reports Q3 EPS (15c), consensus (75c)

    11/13/2023 - 07:08am
  • Orchard Therapeutics announces presentation of study of OTL-203 at ESGCT

    10/26/2023 - 07:19am
  • Orchard Therapeutics announces multiple presentations at ESGCT 2023

    10/24/2023 - 07:25am
  • Fly Intel: Pre-market Movers

    10/5/2023 - 09:03am
  • Orchard Therapeutics downgraded to Hold from Buy at Stifel

    10/5/2023 - 08:40am
  • Orchard Therapeutics to be acquired by Kyowa Kirin for $16.00 per share

    10/5/2023 - 05:10am
  • Biotech Alert: Searches spiking for these stocks today

    9/22/2023 - 11:14am
dynamic_feed Breaking News